University of Pittsburgh Cancer Institute Magee-Womans Hospital — Pittsburgh, Pennsylvania

University of Pittsburgh Cancer Institute Magee-Womans Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pittsburgh Cancer Institute Magee-Womans Hospital has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh Cancer Institute Magee-Womans Hospital?

University of Pittsburgh Cancer Institute Magee-Womans Hospital has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh Cancer Institute Magee-Womans Hospital conducted?

University of Pittsburgh Cancer Institute Magee-Womans Hospital has 1 clinical trials on record. Their work covers Breast Cancer.

Is University of Pittsburgh Cancer Institute Magee-Womans Hospital accredited by Crixeo Clinical Trials?

University of Pittsburgh Cancer Institute Magee-Womans Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh Cancer Institute Magee-Womans Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.